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Abstract. A straightforward application of semi-supervised machine learn-
ing to the problem of treatment effect estimation would be to consider data
as “unlabeled" if treatment assignment and covariates are observed but out-
comes are unobserved. According to this formulation, large unlabeled data
sets could be used to estimate a high dimensional propensity function and
causal inference using a much smaller labeled data set could proceed via
weighted estimators using the learned propensity scores. In the limiting case
of infinite unlabeled data, one may estimate the high dimensional propensity
function exactly. However, longstanding advice in the causal inference com-
munity suggests that estimated propensity scores (from labeled data alone)
are actually preferable to true propensity scores, implying that the unlabeled
data is actually useless in this context. In this paper we examine this para-
dox and propose a simple procedure that reconciles the strong intuition that a
known propensity functions should be useful for estimating treatment effects
with the previous literature suggesting otherwise. Further, simulation studies
suggest that direct regression may be preferable to inverse-propensity weight
estimators in many circumstances.
Key words and phrases: Causal inference, Semi-supervised learning, Unla-
beled data, Propensity score.
1. INTRODUCTION
In their seminal paper, Rosenbaum and Rubin (1983) show that the propensity score, the
probability of receiving the treatment conditional on control covariates, is a sufficient statistic
for estimating treatment effects. They show that rather than needing to balance on a potentially
high dimensional vector of control variables, one need only balance on the one-dimensional
propensity score. In practice, however, researchers do not know the propensity function —
the mapping from the covariates to the treatment probabilities — in advance; it must estimate
from data. Unfortunately, learning the propensity function can be quite difficult when there
are many controls and its parametric form is unknown. Linear logistic regression is often the
uncritical method of first resort and even in that familiar setting estimation can be challenging
with limited data.
Notably, propensity score approaches only require learning a function of the treatment as-
signment and control variables; the response variable is not utilized at this preliminary stage.
This raises the possibility of incorporating side data for which responses aren’t measured,
so-called “unlabeled” data, in the parlance of semi-supervised learning (Zhu and Goldberg
(2009)) to assist in estimating the propensity function. Provided that such data is available,
the propensity function can be inferred more accurately than would be possible with the la-
beled data alone. In the limit, one can imagine learning the propensity function arbitrarily
accurately, thereby realizing the holy grail conveyed by Rosenbaum and Rubin (1983) of be-
ing able to do causal inference with a one-dimensional control variable.
1
2However, it was famously shown by Hirano, Imbens and Ridder (2003) that true propensity
scores are actually worse – in the sense of yielding asymptotically higher variance estimates of
the treatment effect – than ones estimated from the labeled data alone! This observation would
seem to dash any hope of leveraging unlabeled data as described above. Similar results were
demonstrated by Lunceford and Davidian (2004) in the context of stratification and weighting
estimators with parametric propensity models.
This paper unpacks this apparent paradox in an effort to provide practical guidance to
applied researchers interested in estimating treatment effects from observational data. We find
that the uselessness of the true propensity function have been greatly exaggerated, reviving the
potential for unlabeled data to assist in propensity function estimation, i.e. semi-supervised
treatment effect estimation.
2. PROBLEM STATEMENT AND NOTATION
2.1 Notation
Throughout the paper we use the following conventions:
• Random variable: italicized, uppercase letter (e.g. X , A, ...)
• Scalar realization of random variable: italicized, lowercase letter (e.g. x, a, ...)
• Vector realization of random variable: lowercase letter (e.g. x, a, ...)
• Matrix realization of random variable: bold, uppercase letter (e.g.X,A, ...)
• Metric space of random variable’s support: math calligraphy letter (e.g. X , A, ...)
We first draw a distinction between observational and experimental studies for treatment
effect estimation. In experimental settings, the treatment of interest is deliberately random-
ized according to a pre-specified design, typically with the goal of enabling straightforward
identification of the treatment effect. In observational settings, data on treatment, outcome
and covariates are observed without any direct manipulation. Researchers wishing to infer
treatment effects with observational data must rely on a series of assumptions, which we now
introduce.
Let Y refer to the outcome of interest, Z denote a binary treatment assignment, and
X be a vector of covariates drawn from covariate space X . We use the potential out-
comes notation Y 1 and Y 0 to refer to the counterfactual values of Y when Z = 1 and
Z = 0 (Hernan and Robins (2020)). Our estimand of interest, is the average treatment effect:
E[Y 1 − Y 0].
Since the potential outcomes (Y 1, Y 0) are never observed simultaneously, we rely on a
number of identifying assumptions common to the causal inference literature (Rubin (1980),
Rosenbaum and Rubin (1983), Hernan and Robins (2020)):
1. Stable unit treatment value assumption (SUTVA): for any sample of size n with Y ∈ Y
and Z ∈ Z , (Y 1i , Y
0
i )⊥Zj for all i, j ∈ {1, ..., n} with j 6= i
2. Positivity: 0< P(Z = 1 |X =X)< 1 for all X ∈X
3. Conditional exchangeability: (Y 1, Y 0)⊥Z |X
Taken together, these assumptions enable identification of average treatment effects using
observational data after adjusting for the effect of X on Z and Y . Thus, we can rewrite our
estimand as ATE = E[Y 1 − Y 0] = EX [E[Y |X,Z = 1]− E[Y |X,Z = 0]]. There are many
ways to adjust for X in estimating the ATE, but this paper focuses on methods that use the
propensity score. Rosenbaum and Rubin (1983) define the propensity score as p(X) = P(Z =
1 |X) and show that p(X) has several desirable properties:
1. X ⊥Z | p(X)
2. (Y 1, Y 0)⊥Z | p(X)
In short, the propensity score can be used to ensure covariate balance across treatment
groups and the resulting covariate balance deconfounds the treatment effect estimate of Z on
Y . The deconfounding property of p(X) implies that the treatment effect estimand can be
rewritten as ATE= E[Y 1 − Y 0] = Ep(X)[E[Y | p(X),Z = 1]− E[Y | p(X),Z = 0]].
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2.2 Confounders, Instruments and Pure Prognostic / Moderator Variables
Above, we let X refer to the set of covariates of Y and Z , but for the purposes of this
discussion, we introduce a taxonomy of covariate types. First, observe that, using a similar
framing as Hahn et al. (2020), the relationship between Y , Z and X can be expressed as:
E [Y |Xµ,Xτ ,Xpi] = µ (Xµ) + τ (Xτ )Z
P (Z = 1 |Xpi) = π (Xpi)
whereXµ refers to the set of prognostic variables,Xτ refers to the set of moderator variables,
and Xpi refers to the set of propensity variables. We consider that any variable in X can be
classified as follows:
1. Confounder: Any variable which appears in Xpi and either of Xµ or Xτ
2. Pure prognostic / moderator variable: Any variable which appears in eitherXµ,Xτ ,
or both, but not in Xpi
3. Instrument: Any variable which appears in Xpi and not in Xµ nor Xτ (this is a “pure
propensity” variable)
4. Extraneous variable: Any variable in X which appears in none of Xτ , Xµ, or Xpi)
2.3 Estimated vs true propensities
Hirano, Imbens and Ridder (2003) discuss the inverse-propensity weighted estimator of
average treatment effect, which estimates the ATE as follows
ATEIPW =
(
1
N
N∑
i=1
YiZi
p(Xi)
−
Yi(1−Zi)
1− p(Xi)
)
They show that even when the true propensities are known, using them directly in the IPW
estimator is asymptotically inefficient. We consider the finite sample variance properties of
this estimator on a simple data generating process, which we define below:
• Covariates: X1,X2 ∼ Bernoulli(1/2), letting X = (X1,X2)
• Propensity function: p(X) = 1/ (1 + exp{−(α1 +α2X1)})
• Treatment: Z ∼ Bernoulli(p(X))
• Outcome: Y ∼N (γ1X1 + γ2X2 + τZ,1)
We let the random variable N denote the overall sample size and define subset-specific
sample sizes as follows:
• Nx: the number of observations with X = x
• Nx,z: the number of observations with X = x and Z = z
First, observe in this case that p(X) takes on two distinct values: 1/ (1 + exp{−α1}) if
X1 = 0, and 1/ (1 + exp{−α1 −α2}) if X1 = 1. We can split in the sum into eight parts,
stratifying on the unique values of (X1, X2, Z). For a given stratum, the weights in the
denominator, as well as the Zi and 1 − Zi indicators, are all the same and can be factored
out. We refer to “true propensities” estimator as IPWp(X) to indicate that the true propensity
function, p(X) is the basis for the weights in the denominator. Let px = P(Z = 1 |X = x) =
P(Z = 1 |X1 = x1). The portion of the “true propensities” estimator represented by a given
{X = x} (i.e. {X1 = x1,X2 = x2}) stratum is given by
4IPWp(X),x =
1
N
∑
j:Xj=x
(
YjZj
px
−
Yj(1−Zj)
1− px
)
=
1
N
Nx
Nx
Nx,z
Nx,z
1
px
∑
j:Xj=x,Zj=1
Yj
−
1
N
Nx
Nx
Nx,z=0
Nx,z=0
(1− px)
(1− px)
∑
j:Xj=x,Zj=0
Yj
=
(
Nx
N
)(
pˆx
px
Y¯x,Z=1−
1− pˆx
1− px
Y¯x,Z=0
)
Where IPWp(X) = IPWp(X),X=(0,0)+IPWp(X),X=(1,0)+IPWp(X),X=(0,1)+IPWp(X),X=(1,1)
and pˆx = (Nx,z=1/Nx). We see that replacing the true propensity weights with these empirical
weights results in the following estimator:
IPWp(X),x =
1
N
∑
j:Xj=x
(
YjZj
pˆx
−
Yj(1−Zj)
1− pˆx
)
=
(
Nx
N
)(
Y¯x,Z=1− Y¯x,Z=0
)
We can compare the variances of these two estimators, by first observing that the data are
i.i.d., so that conditional on the number of observations with Z = 1 and X = x, the covari-
ances of the strata means are 0. We derive the variances of the two estimators in Appendix A,
but the key to understanding why V
[
IPWpˆ(X),x
]
≤V
[
IPWp(X),x
]
is to notice that the ratios
(pˆx1/px1) and (1− pˆx)/ (1− px) are random variables which converge to 1 as n→∞ but
are noisy in finite samples. These finite sample imbalances are an ancillary statistic for τ , and
the pˆ(X) estimator conditions on this ancillary statistic for more efficient inference. For a
detailed discussion of the role of ancillary statistics in causal inference, readers are referred
to Chapter 10 of Hernan and Robins (2020) and the references therein.
This result seems to imply a paradox. Even if a propensity function is known exactly, is
the analyst better off ignoring that information and estimating the propensity scores? While it
is true that directly weighting by the true propensities yields higher variances, we show that
the true propensity scores can still be used to achieve efficiency. Consider in this case that
p(X) = 1/ (1 + exp{−α1 − α2X1}), so Z can be modeled via logistic regression on X1,
X2, and an intercept term. Fitting this model on a sample X = (x1,x2) and z would yield
coefficient estimates βˆ1, βˆ2, and βˆ3 such that pˆ(X) =
1
1+exp{−βˆ1−βˆ2x1−βˆ3x2}
, where the true
values of the parameters are β1 = α1, β2 = α2, and β3 = 0. Thus, if we know the true value
of p(X), we can calculate the true β1 + β2x1 + β3x2 by logit transformation
β1 + β2x1 + β3x2 =− log
(
1
p(X)
− 1
)
Since both β1 + β2x1 + β3x2 and βˆ1 + βˆ2x1 + βˆ3x2 are one-dimensional linear functions
of X, we could express βˆ1 − βˆ2x1 − βˆ3x2 = ηˆ0 − log
(
1
p(X) − 1
)
ηˆ1 for some ηˆ0, ηˆ1 ∈ R
and observe that this is equivalent to a logistic regression of Z on a 1-dimensional vector
− log
(
1
p(X) − 1
)
with an intercept term.
This 1-dimensional regression adjustment is similar to the sample correction discussed in
the context of the pˆ(X) estimator, with one key difference: the differences between true and
empirical treatment probabilities are adjusted across the support of p(X) rather than X . In
our two-covariate example, the difference is that p(X) is only a function of X1, so has two
unique values, rather than the four distinct values of X .
We introduce the following shorthand to refer to the three estimators:
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1. p(X): IPW estimator using the true propensity function, p(X) as weights
2. pˆ(X): IPW estimator using the covariate-estimated propensity function, pˆ(X), as
weights
3. pˆ(p(X)): IPW estimator using the true propensity function, p(X), as a 1-dimensional
variable for estimating sample propensity weights
Hirano, Imbens and Ridder (2003) and the example above demonstrate that the pˆ(X) es-
timator is lower variance than the p(X) estimator. However, we see in Appendix B that the
pˆ(p(X)) estimator has lower variance than the pˆ(X) estimator as long as the following two
conditions are satisfied:
• X2 is not a pure prognostic / moderator variable: E
[
Y¯X1=x1,X2=1,Z=z
]
= E
[
Y¯X1=x1,X2=0,Z=z
]
for all x1, z. In our simple data generating process, this is true if γ2 = 0.
• The outcome variance does not differ along the support ofX2: V
[
Y¯X1=x1,X2=1,Z=z
]
=
V
[
Y¯X1=x1,X2=0,Z=z
]
for all x1, z. In our simple data generating process, this is true as
the variance of Y is constant with respect to X .
The most interesting takeaway from this result is that the cases in which the pˆ(X) estimator
outperforms the pˆ(p(X)) estimator do not pertain to the intended use of the propensity score,
to deconfound treatment assignment and enable identification of the ATE. The pˆ(X) estimator
can attain a lower variance, but it does so by stratifying on a pure prognostic / moderator
variable, X2. This points to an unintended use of weighting / stratification estimators, rather
than a fundamental problem with using true propensities. Adjusting for pure prognostic /
moderator variables can be achieved by direct regression adjustment, and Hahn et al. (2020)
provide a nonparametric Bayesian approach that shows promising results on a number of
difficult data generating processes.
To demonstrate the difference in variances of the three estimators in finite samples, we
conduct a simulation study. We use the same data generating process discussed in the finite
sample variance calculations above, in which Y is normal,X and Z are Bernoulli, andX has
p = 2 dimensions. In the simulations presented below, we generate 10,000 datasets for each
value of N and estimate the average treatment effect using the IPW estimator, comparing
three possible weighting options:
a) p(X): True propensities ({0.3,0.7})
b) pˆ(X): Estimated propensities (logistic regression of Z on X)
c) pˆ(p(X)): Sample adjustment using true propensities (logistic regression ofZ on logit (p(X)))
N p(X) pˆ(X) pˆ(p(X))
15 1.80 0.91 0.81
25 1.41 0.69 0.52
50 1.00 0.38 0.32
100 0.70 0.24 0.22
250 0.44 0.14 0.14
TABLE 1
Standard deviation of IPW estimates using different weighting approaches
10,000 simulations per N
p = 2 (value of N for which variances converge depends on p)
Our simulations confirm the points made in Hirano, Imbens and Ridder (2003) and
Rosenbaum (1987) that using the true propensities directly leads to higher variances in finite
samples. However, we also see that the true propensities can be used in a one-dimensional
model of Z to attain even lower variances than estimators using the fitted propensities.
62.4 Semi-supervised treatment effect estimation
In practice, knowledge of the exact true propensity function is unlikely outside of random-
ized experiments. However, it is certainly possible to imagine investigators having access to
auxiliary data that enable more accurate estimates of the true propensities. The received wis-
dom of Hirano, Imbens and Ridder (2003), Lunceford and Davidian (2004), and Rosenbaum
(1987) would seem to imply that such accuracy gains impede efficient estimation of the ATE.
The primary challenge in using propensity scores estimated from a larger auxiliary dataset
stems from the utility of conditioning on finite sample treatment probabilities in weighting
estimators. However, we have shown in Section 2.3 that the same variance reduction can be
achieved by conditioning on finite sample probabilities formed by p(X) rather than X , and
this result extends to an estimate of p(X) derived from arbitrarily large datasets.
We can formalize the notion of using a large auxiliary dataset in estimating the ATE by
framing it as a semi-supervised learning problem. Semi-supervised learning refers to a broad
class of techniques that combine labeled and unlabeled data in statistical learning problems
(Zhu and Goldberg (2009), Belkin, Niyogi and Sindhwani (2006), Liang, Mukherjee and West
(2007)). Consider a dataset with N observations. As above, we let Y , Z , and X denote
outcome, treatment, and covariates, respectively. We refer to the data points with observed
outcomes as “labeled data," and let No refer to the number of such labeled observations
and Nm =N −No refer to the number of data points with missing outcomes. We index an
outcome’s status as missing or observed byM .
Following the notation of Liang, Mukherjee and West (2007), we denote “unlabeled,” or
marginal, data as
• Xm = {Xi; i=No + 1, ...,No +Nm}, and
• Zm = {Zi; i=No + 1, ...,No +Nm}
Similarly, we denote “labeled” data as
• Y o = {Yi; i= 1, ...,No},
• Xo = {Xi; i= 1, ...,No}, and
• Zo = {Zi; i= 1, ...,No},
We observe that M = 1 where X,Z ∈ (Xm,Zm) and M = 0 elsewhere. The discussion in
Section 2.3 shows that the set of marginal (Xm,Zm) data can be put to good use in estimating
the average treatment effect as follows:
1. Obtain an estimate, pe(X) of the true propensities using the labeled and unlabeled data
(X,Z)
2. Adjust the estimated propensities to the labeled sample bymodelingZo ∼ Bernoulli (pe(Xo)),
and denote these adjusted estimates by p∗(Xo)
3. Estimate the ATE using only the labeled data (Y o, Zo, and p∗(Xo))
As with other constructions in the semi-supervised learning literature, this framing allows
us to profitably use information about the statistical patterns in the unlabeled data (in this
case, p(Z = 1 |X)) to better estimate an effect among the labeled data (E[Y 1 − Y 0]).
3. SIMULATIONS
We conduct several simulation studies to understand the phenomena discussed above in
more depth. While logistic regression is often a natural choice for estimating propensity
scores, Lee, Lessler and Stuart (2010) point out that the assumptions required for logistic
regression are not always warranted and they examine propensity score estimation using a
number of machine learning methods, including CART (Breiman et al. (1984)) and Random
Forest (Breiman (2001)).
This paper proceeds similarly, but instead relies on Bayesian Additive Regression Trees
(BART) (Chipman et al. (2010)). 1 BART is a nonparametric Bayesian tree ensemble method
1Code can be found at https://github.com/andrewherren/semi-supervised-propensity
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that estimates complex functions via a sum of weak regression or classification trees. In the
case of our IPW estimator, we also consider a logistic propensity model in order to investigate
how inferences can be harmed by model mis-specification.
3.1 Estimators
We employ three estimators which use propensity scores in our simulation study:
• Inverse Propensity Weighted (IPW) estimator (Hirano, Imbens and Ridder (2003)), in-
troduced in Section 2.3 and defined as
ATEIPW =
1
N
N∑
i=1
(
YiZi
p(Xi)
−
Yi(1−Zi)
(1− p(Xi))
)
• TargetedMaximumLikelihood Estimator (TMLE) (van der Laan (2010a), van der Laan
(2010b), Gruber and van der Laan (2009))
ATETMLE =
1
N
N∑
i=1
(Q∗ (Zi = 1,Xi)−Q
∗ (Zi = 0,Xi))
where Q∗ (Zi,Xi) represents a semi-parametric model of the outcome Y which incor-
porates the propensity score.
• Bayesian Causal Forests (BCF) (Hahn et al. (2020))
ATEBCF =
1
N
N∑
i=1
(
f¯(Xi,Zi = 1)− f¯(Xi,Zi = 0)
)
where f¯(Xi,Zi) is an average of posterior simulations (across all simulations) of two
BART models, defined as f(Xi,Zi) = µ(Xi, p(Xi)) + τ(Xi)Zi.
3.2 Simulation approaches
Given the two step nature of each of the above estimators, in which a propensity model
is first constructed and its estimates then used to calculate an average treatment effect, we
consider three approaches to treatment effect estimation:
• Complete case analysis: We discard all unlabeled data samples, estimate pˆ(Xo), and
then compute average treatment effects on only the labeled observations.
• Semi-supervised: We use the labeled and unlabeled X and z values to estimate pˆ(X)
and then use the pˆ(Xo) predictions to compute average treatment effects on the labeled
observations.
• True propensities: Simulation studies provide us with actual probabilities of receiving
treatment, so we can use these true p(Xo) to compute average treatment effects on
the labeled observations. Of course, in most real world applications, the exact true
propensities will not be available, and we consider this scenario as a limiting case in
which an arbitrarily large amount of unlabeled data were available for modeling pˆ(X).
3.3 Interval construction
We construct confidence intervals for our simulations as follows:
• IPW (logit) and IPW (BART): We compute the asymptotic standard error assuming a
logistic propensity model as in Cerulli (2014)
• TMLE: We use the 95% confidence interval produced by the tmle R package
• BCF: We construct a 95% credible interval using posterior samples of the treatment
effect
3.4 Evaluation metrics
We evaluate the results of our simulations using the following metrics.
• RMSE: root mean squared error of estimated treatment effects
• Bias: difference between true (simulated) ATE and average estimated ATE
• Coverage: fraction of 95% confidence / credible intervals that contain the true ATE
83.5 Data Generating Process Simulations
For simulated covariates, outcomes, and treatment effects, we use a subset of the data
generating processes tested in Hahn et al. (2020).
Y = µ(X) + τZ + ε
µ(X) =


3 +X1X3, X5 = 1,
X1X3, X5 = 2
−3 + x1X3, X5 = 3
X1,X2,X3 ∼N (0,1)
X4 ∼ Bernoulli(0.5)
X5 ∼ Categorical(0.25,0.5,0.25)
τ = 3
ε∼N (0,1)
There are p = 5 covariates, the first three of which are independent standard normal vari-
ables, the fourth of which is binary, and the fifth is an unordered categorical variable with
values 1,2,3. Treatment effects are homogeneous (τ = 3), and the outcome is determined by
a combination of treatment effects and a piecewise interaction function of three of the co-
variates (µ(X) = 1 + g(X5) +X1X3, where g(X) = 2 if X = 1, g(X) =−1 if X = 2, and
g(X) =−4 if x= 3). µ(X) is often referred to as a prognostic effect and can be conceptual-
ized as the expected value of the outcome for individuals who do not receive the treatment.
For treatment assignment, we consider two cases:
1. P (Z = 1 |X) = 0.5
2. P (Z = 1 |X) = 0.8Φ(3µ(X)/s− 0.5X1) + 0.05 + u/10
• Φ(·) is the standard normal CDF
• s is the sample standard deviation of simulated observations of µ(X)
• u∼Uniform(0,1)
The first treatment assignment mechanism mirrors a simple balanced randomized exper-
iment. This presents relatively straightforward inference, as there is no confounding, but
it allows us to simulate the phenomenon of including non-confounders in the propensity
model. The second treatment assignment mechanism is described as “Targeted Selection"
in Hahn et al. (2020), and refers to the phenomenon of assigning treatment based on the ex-
pected value of the outcome for those who don’t receive treatment.
In order to simulate the process by which outcomes are unlabeled, we assume a fixed
overall sample size of 5,000 and randomly label 50, 100, or 500 observations so that M
is not correlated with Y , X , or Z . This parallels the notion of “missing completely at ran-
dom” (MCAR) in the missing data literature (Little and Rubin (2002)), though our problem
is slightly different. We treat our unlabeledXm and Zm as auxiliary data that may be helpful
in estimating the ATE rather than treating our unobserved Y m as missing data to be imputed
or otherwise estimated. Before proceeding to a more detailed discussion of the simulation
results, we briefly summarize the key takeaways:
• Using unlabeled data will harm inferences in the case of a mis-specified propensity
model, as confidence intervals narrow around a biased estimate
• BCF and IPW/BART work best in the case of targeted selection
• While randomized treatment assignment makes ATE estimation much easier, unlabeled
data can still be useful in this case for variance reduction purposes
3.6 Simulation results under targeted selection
We first examine the targeted selection case, in which treatment assignment is correlated
with the prognostic effect.
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3.6.1 IPW (logit)
The table below shows the results for 500 simulations using an IPW estimator and propen-
sities estimated by logistic regression. The targeted selection function is nonlinear and thus
a logistic propensity model is misspecified. We see that the results are badly biased, except
those which use the true propensities and are not impacted by the model misspecification.
Furthermore, we observe that using unlabeled data and increasing sample size is harmful, as
the variance is reduced around a biased estimate, leading to worse interval coverage.
Approach N # labeled ATE RMSE Bias Coverage
Complete Case 5,000 50 3.49 0.89 0.49 0.67
Complete Case 5,000 100 3.48 0.68 0.48 0.77
Complete Case 5,000 500 3.50 0.51 0.50 0.59
Semi-supervised 5,000 50 3.48 0.97 0.48 0.67
Semi-supervised 5,000 100 3.56 0.73 0.56 0.72
Semi-supervised 5,000 500 3.50 0.52 0.50 0.55
True propensities 5,000 500 2.99 0.25 -0.01 0.89
TABLE 2
500 simulations with outcomes MCAR
3.6.2 IPW (BART)
The table below shows the results for 500 simulations using an IPW estimator and propen-
sities estimated by BART. In this case, the propensity model is not mis-specified, and we
observe that the use of unlabeled data reduces bias and increases interval coverage.
Approach N # labeled ATE RMSE Bias Coverage
Complete Case 5,000 50 3.90 0.90 0.90 0.47
Complete Case 5,000 100 3.79 0.79 0.79 0.39
Complete Case 5,000 500 3.50 0.50 0.50 0.36
Semi-supervised 5,000 50 3.00 0.85 -0.00 0.73
Semi-supervised 5,000 100 3.00 0.58 -0.00 0.86
Semi-supervised 5,000 500 3.00 0.26 -0.00 0.90
True propensities 5,000 500 2.99 0.25 -0.01 0.89
TABLE 3
500 simulations with outcomes MCAR
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3.6.3 TMLE
The table below shows the results for 500 simulations using a TMLE estimator and propen-
sities estimated by BART. In this case, the propensity model is not mis-specified, however,
we observe that the TMLE estimator achieves poor interval coverage, even in large sample
sizes where the average bias is lower.
Approach N # labeled ATE RMSE Bias Coverage
Complete Case 5,000 50 3.58 0.62 0.58 0.35
Complete Case 5,000 100 3.44 0.47 0.44 0.33
Complete Case 5,000 500 3.12 0.15 0.12 0.63
Semi-supervised 5,000 50 3.33 0.51 0.33 0.60
Semi-supervised 5,000 100 3.24 0.35 0.24 0.64
Semi-supervised 5,000 500 3.07 0.13 0.07 0.80
True propensities 5,000 500 3.05 0.12 0.05 0.84
TABLE 4
500 simulations with outcomes MCAR
3.6.4 BCF
The table below shows the results for 500 simulations using a BCF estimator and propensi-
ties estimated by BART. BCF was designed in part to handle the case of targeted selection,
and we see that it produces unbiased estimates with high coverage as more unlabeled data is
incorporated.
Approach N # labeled ATE RMSE Bias Coverage
Complete Case 5,000 50 3.54 0.99 0.54 0.70
Complete Case 5,000 100 3.43 0.80 0.43 0.80
Complete Case 5,000 500 3.06 0.37 0.06 0.96
Semi-supervised 5,000 50 3.26 0.80 0.26 0.77
Semi-supervised 5,000 100 3.15 0.58 0.15 0.86
Semi-supervised 5,000 500 3.03 0.37 0.03 0.98
True propensities 5,000 500 3.01 0.32 0.01 0.98
TABLE 5
500 simulations with outcomes MCAR
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3.7 Simulation results under randomized assignment
We now turn to the randomized treatment assignment scenario.
3.7.1 Complete case
The table below shows the results for 500 simulations using the complete case approach
across all four estimators. We see in this case that all methods produce unbiased estimates
of the ATE as sample size increases, and with the exception of the TMLE estimator, the
approaches all achieve high coverage of the true treatment effect.
Estimator N # labeled ATE RMSE Bias Coverage
IPW (logistic) 5,000 50 3.03 0.39 0.03 0.99
IPW (logistic) 5,000 100 2.97 0.23 -0.03 1.00
IPW (logistic) 5,000 500 3.00 0.10 0.00 1.00
IPW (BART) 5,000 50 2.67 0.46 -0.33 0.98
IPW (BART) 5,000 100 2.75 0.31 -0.25 0.99
IPW (BART) 5,000 500 2.90 0.13 -0.10 1.00
TMLE 5,000 50 2.96 0.33 -0.04 0.72
TMLE 5,000 100 2.96 0.20 -0.04 0.79
TMLE 5,000 500 3.00 0.08 0.00 0.86
BCF 5,000 50 2.90 0.69 -0.10 0.79
BCF 5,000 100 2.93 0.47 -0.07 0.87
BCF 5,000 500 2.99 0.22 -0.01 0.96
TABLE 6
500 simulations with outcomes MCAR
3.7.2 Semi-supervised
Below are the same simulations using the semi-supervised approach. For both of the weight-
ing estimators, we observe that the semi-supervised approach yields a higher variance. This
is an example of the phenomenon discussed in Section 2.3 – the sample imbalances among
the labeled data are an ancillary statistic for τ and conditioning on that statistic leads to lower
variance. We note that this problem could be overcome using a sample adjustment of Z on
the unlabeled propensity score estimates. We also observe in this case that bias of the IPW
estimators decreases with the use the unlabeled data, which suggests the use of the marginal
data for two reasons:
• Using only labeled data can lead to biased treatment effect estimates in finite samples
• With an appropriate adjustment, the variance of estimators that use marginal propensi-
ties can be reduced to mirror estimators using only labeled data
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Estimator N # labeled ATE RMSE Bias Coverage
IPW (logistic) 5,000 50 3.00 0.65 -0.00 0.90
IPW (logistic) 5,000 100 3.00 0.47 -0.00 0.93
IPW (logistic) 5,000 500 3.00 0.20 0.00 0.97
IPW (BART) 5,000 50 2.97 0.65 -0.03 0.91
IPW (BART) 5,000 100 2.97 0.47 -0.03 0.93
IPW (BART) 5,000 500 2.98 0.20 -0.02 0.96
TMLE 5,000 50 2.95 0.33 -0.05 0.76
TMLE 5,000 100 2.96 0.20 -0.04 0.81
TMLE 5,000 500 3.00 0.08 0.00 0.87
BCF 5,000 50 2.91 0.70 -0.09 0.82
BCF 5,000 100 2.94 0.46 -0.06 0.90
BCF 5,000 500 2.99 0.22 -0.01 0.97
TABLE 7
500 simulations with outcomes MCAR
4. DISCUSSION
4.1 Resolving the estimated propensity paradox
Section 2.3 reviews the paradox of using estimated propensities to reduce variance in
weighting estimators, even if true propensities are known (cited in Hirano, Imbens and Ridder
(2003), Rosenbaum (1987), and Lunceford and Davidian (2004)). We believe this issue de-
serves a detailed discussion, as it contains a number of subtleties and its central claim (i.e.
that estimated propensities are “better” than true propensities from a variance perspective)
persists in the causal inference community to this day.
4.1.1 What the paradox actually implies
The mechanism by which conditioning on estimated propensities can reduce variances has
two components:
a) Adjusting for finite sample differences between true propensities and empirical treatment
probabilities
b) (For weighting estimators) effecting a variant of direct regression adjustment by stratifying
on pure prognostic / moderator variables
We noted in Section 2.3 that the variance implications of (a) can be mitigated by modeling
Z directly from the true propensity score, if it is available. This leaves (b) as a concern, which
is no longer a paradox of which propensity scores to use, but rather which estimator to use. In
particular, this is not a concern for direct regression estimators which allow for adjustment by
prognostic / moderator variables. Indeed, our simulations using BCF demonstrate this point.
4.1.2 Bias-variance tradeoff
Absent from most of the literature on estimated vs true propensities is the possibility of
model misspecification in estimating propensities. Thus, points (a) and (b) above represent
perhaps an optimistic view which is that the propensity function can be estimated arbitrarily
well on finite samples. In this case, concerns about variance outweigh concerns about bias.
However, our simulations show that in plausible real-world scenarios, propensity-based ATE
estimators that rely only on labeled data can be severely biased. Indeed, while Section 2.3
shows that the variance of the “true propensities” estimator can be higher than either of the two
adjusted estimators, we see in our simulations that the true propensities estimator typically
achieves the lowest RMSE, implying that bias overwhelms variance in many cases.
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4.2 Propensity model specification
Though there may be benefits to using estimated propensity scores, in practice, calcu-
lating propensity scores introduces a new set of risks. The simulations in Section 3 show
that a misspecified propensity model can bias estimates, sometimes drastically. It may
seem natural, then, to treat a propensity model as any other supervised learning problem,
with variable selection, model validation, and diagnostics to ensure a proper fit. Indeed,
McCaffrey, Ridgeway and Morral (2004) use boosting to estimate propensities, in part for
the automatic variable selection and flexible model specification that tree ensembles provide.
Their results show that using boosting for a propensity model leads to better covariate balance
and lower standard errors than a logistic propensity model.
However, Hernan and Robins (2020) caution that traditional model selection techniques
may be of dubious utility in constructing propensity models. They note that the purpose of
the propensity score is to control for confounding variables, not predict Z from X arbitrarily
well. They are careful to point out that a purely data-driven approach to model selection
runs the risk of including variables, such as colliders, mediators, or post-treatment variables,
that jeopardize identification of treatment effects. They also advise that, even when treatment
effects are identified, including instruments in a propensity model can increase the variance
of treatment effect estimates by pushing estimated propensities closer to 0 and 1.
At first glance, this point would seem to argue against our recommendation to use semi-
supervised machine learning in ATE estimation. Indeed, naively overfitting a propensity
model is a surefire way to get noisy (and perhaps even biased) treatment effect estimates.
However, we believe that a number of practical steps can be taken to mitigate these concerns.
First, estimated propensity scores should always be visualized or otherwise inspected to
ensure that they are not numerically close to 0 and 1. Second, regularization methods (such
as ℓ2 normalization or certain types of ensembles), can be used instead of logistic regression
to minimize the risk of estimating propensity scores close to 0 and 1. Finally, subject matter
expertise should always play a role in building propensity models. In many applied prob-
lems, especially those with a high-dimensional covariate space, the challenge of constructing
an accurate causal graph is highly non-trivial. Insofar as subject matter expertise can iden-
tify variables such as colliders, post-treatment variables, or non-confounders, such variables
should of course be excluded from any propensity model.
Researchers who are concerned about an underlying causal graph invalidating their propen-
sity model can also turn to the causal discovery literature (i.e. Peters, Janzing and Schölkopf
(2017)). Specifically, Entner, Hoyer and Spirtes (2013) present an approach to the problem of
identifying confounders for adjustment in a causal model. In practice, the challenge of speci-
fying (or estimating from the data) a causal graph can present a number of pitfalls beyond the
scope of this paper. We suffice to say that there is no easy replacement for domain expertise
in this process, but that this point applies to propensity models that use fully labelled data as
well that those that use unlabeled data.
In order to better understand the pitfalls of including non-confounders in a propensity
model, we test several possibilities in a simulation study. Letting Xj be a variable in a set of
p covariates, we consider four cases:
a) Case 1: Xj is a confounder and is included in a propensity model
b) Case 2: Xj is not a confounder and is included in a propensity model
c) Case 3: Xj is a confounder and is not included in a propensity model
d) Case 4: Xj is not a confounder and is not included in a propensity model
Cases 1 and 4 are ideal, while cases 2 and 3 both fail to properly account for the true un-
derlying causal model. The question we are concerned with is whether erring on the side of
including non-confounders in a propensity model (case 2) is as harmful to inference as ig-
noring true confounders (case 3). To do this, we simulate 100 datasets of n=1,000 from the
following data generating process:
Y =Xβ + τZ + ε
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X,ε∼N (0,1)
τ = 3
p=
(
1
1 + exp(−Xγ)
)
Z ∼ Bernoulli(p)
For all variables except Xj , the β and γ coefficients for the outcome and propensity models
are drawn uniformly at random from a range of (−0.5,0.5) and (−0.3,0.3), respectively.
For the scenarios in which Xj is a confounder (that is, Xj impacts both Y and Z), we set
βXj = 0.5. Each of our simulations assume some relationship between xj and z, and we vary
γXj between {0,1,10} to test the extent to which conditioning on Xj in a propensity model
separates the treatment and control groups.
Below we see the simulated bias, RMSE, and 95% interval coverage of each of the four
cases, using BCF with a BART propensity model and γXj = 1
Case Xj confounder? Xj in pˆ? Bias RMSE Coverage
1 Yes Yes 0.004 0.098 89%
2 No Yes -0.008 0.096 88%
3 Yes No 0.068 0.109 84%
4 No No -0.007 0.087 87%
TABLE 8
ATE estimation using BCF, γXj = 1
We see little difference in the results across each of the cases, because the influence of Xj
on Y is modest in the confounded case. Below is the same set of outputs for γXj = 10.
Case Xj confounder? Xj in pˆ? Bias RMSE Coverage
1 Yes Yes 0.033 0.253 91%
2 No Yes -0.09 0.262 87%
3 Yes No 0.24 0.252 80%
4 No No -0.045 0.126 98%
TABLE 9
ATE estimation using BCF, γXj = 10
We see that cases 1 and 4 exhibit the best performance (since they properly incorporate the
true causal graph), but even whenXj and Z are strongly related, includingXj in a propensity
model whenXj is not a confounder is less harmful than excludingXj when it is a confounder.
To understand why, we briefly review the discussion of “regularization-induced confounding"
(RIC) covered in Hahn et al. (2020).
As we have seen in our simulations, classic parametric models of a treatment assignment
are vulnerable to misspecification. While this shortcoming suggests the use of flexible ma-
chine learning methods to estimate propensity scores, such methods run the risk of overfitting
the data and estimating propensities close to 0 or 1. In addition to numeric instability of
weighting estimators, such overfitting can also violate the positivity or conditional exchange-
ability assumption. Researchers who want to fit flexible propensity models while avoiding
overfitting can use regularized machine learning methods, such as BART. Hahn et al. (2020),
building on Hahn et al. (2018), show that a naive regularized model can bias treatment effect
estimates. Their proposed solution, BCF, controls this bias by incorporating the estimated
propensities as a feature in a regression model predicting E(Y | Z = 0, pˆ(X)).
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In our case, since the simulation studies above are conducted using BCF with a BART
propensity model, we avoid some of the common problems of overfit propensity models while
also recovering unbiased estimates of the average treatment effect. This explains why includ-
ing a non-confounder, Xj , which is strongly predictive of Z in the propensity model doesn’t
harm inference of the ATE by nearly as much as excludingXj when it is a confounder.
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APPENDIX A: VARIANCE DERIVATIONS FOR IPWp(X) VS IPWpˆ(x)
Consider the data generating process of Section 2.3. We condition on a sample of size n
and observed values of X, such that nx is also observed. We derive the variance of the IPW
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estimators for an arbitrary {X = x} stratum and then conclude that the result holds across
the support of X . We randomize over the sample sizes of treated units, which we model as
Nx,z=1 ∼ Binomial(nx, px):
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]
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Since variances are nonnegative and both nxpx(1−px)+n
2
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2
x
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2
x
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2
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2 >
1 for nx > 0 and 0 < px < 1, we see that V
[
IPWp(x),x
]
> V
[
IPWpˆ(x),x
]
. Since X = x has
been arbitrary, this result applies to all {X = x} strata and thus it holds in expectation across
the support of X .
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APPENDIX B: VARIANCE DERIVATIONS FOR IPWpˆ(x) VS IPWpˆ(p(x))
Now, we compare the variance of the pˆ(p(X)) estimator with that of the pˆ(X) estima-
tor. These two estimators differ only in their use of X2. Since p(X) = f(X1), the pˆ(p(X))
estimator is equivalent to a stratification estimator using only X1, while the pˆ(X) estima-
tor stratifies on both X1 and X2. In this derivation, we condition on a sample of size n and
observed values of x1 and z, so that nx1,z is observed. We randomize over X2, deriving the
variance of the IPW estimators for an arbitrary {X1 = x1,Z = 1} stratum and concluding
that the result holds across the support of X and Z . To represent the randomization over X2
at the level of a {X1 = x1} stratum, we introduce two binomial random variables:
• Nx1,X2=1,z=1 ∼ Binomial(nx1,z=1,1/2)
• Nx1,X2=1,z=0 ∼ Binomial(nx1,z=0,1/2)
We can decompose a given {X1 = x1} stratum of the pˆ(p(X)) estimator as follows
IPWpˆ(p(x)),x1 =
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)
We compute the variance of this stratum-specific estimator via the law of total variance
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If X2 has no pure prognostic / moderating impact on Y , then it is true that
• E
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when X2 is not a pure prognostic / moderator variable.
Now, observe that a given {X1 = x1} stratum of the pˆ(X) estimator can be written as
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To obtain the variance of this estimator, we again apply the law of total variance
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and
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We can compare the variances of pˆ(p(x)) and pˆ(x) without evaluating the expectation over
X2 for pˆ(x) by comparing the conditional variance terms of the two expressions.
Focusing on the first two terms of the conditional variance expressions (corresponding to
X1 = x1 and Z = 1), we see that
V
[
IPWpˆ(x),x1,z=1 |Nx1,X2=1,z=1
]
=
(
Nx1,X2=1
n
)2 V [YX1=x1,X2=1,Z=1]
Nx1,X2=1,z=1
+
(
Nx1,X2=0
n
)2 V [YX1=x1,X2=0,Z=1]
Nx1,X2=0,z=1
=
1
n2
(Nx1,X2=1,z=1 +Nx1,X2=1,z=0)
2V [YX1=x1,X2=1,Z=1]
Nx1,X2=1,z=1
+
1
n2
(Nx1,X2=0,z=1 +Nx1,X2=0,z=0)
2V [YX1=x1,X2=0,Z=1]
Nx1,X2=0,z=1
and also that
V
[
IPWpˆ(p(x)),x1,z=1 |Nx1,X2=1,z=1
]
=
1
n2
[
(nx1)
2 (Nx1,X2=1,z=1V [YX1=x1,X2=1,Z=1] +Nx1,X2=0,z=1V [YX1=x1,X2=0,Z=1])
(Nx1,X2=1,z=1 +Nx1,X2=0,z=1)
2
]
where nx1 = (Nx1,X2=1,z=1 +Nx1,X2=1,z=0) + (Nx1,X2=0,z=1 +Nx1,X2=0,z=0)
If V [YX1=x1,X2=1,Z=1] =V [YX1=x1,X2=0,Z=1] then we can set v =V [YX1=x1,X2=1,Z=1] =
V [YX1=x1,X2=0,Z=1] and factor this term out. After this adjustment, the comparison reduces
to evaluating the conditions in which
n2x1
Nx1,X2=1,z=1 +Nx1,X2=0,z=1
≤
N2x1,X2=1
Nx1,X2=1,z=1
+
N2x1,X2=0
Nx1,X2=0,z=1
whereNx1,X2=1 = (Nx1,X2=1,z=1 +Nx1,X2=1,z=0) andNx1,X2=0 = (Nx1,X2=0,z=1 +Nx1,X2=0,z=0)
Multiplying through by 1/2, we see that this is true if the function f(x, y) = (x+y)
2
y
is
convex. Let the domain equal R2+ and observe that a sufficient condition for the convexity of
f is the positive definiteness of the Hessian matrix (Boyd and Vandenberghe (2004)).
H =
(
∂2f
∂x2
∂2f
∂y∂x
∂2f
∂y∂x
∂2f
∂y2
)
=
(
2
y
−2x
y2
−2x
y2
2x2
y3
)
This can be confirmed by observing that the three principal minors are nonnegative
(Harville (1998)):
2
y
≥ 0;
2x2
y3
≥ 0;
4x2
y4
−
4x2
y4
= 0
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Thus, it follows that
n2x1
Nx1,X2=1,z=1 +Nx1,X2=0,z=1
≤
N2x1,X2=1
Nx1,X2=1,z=1
+
N2x1,X2=0
Nx1,X2=0,z=1
The positivity constraint on the convexity of f translates into an assumption of “no empty
strata” for our weighting estimator. Since this result holds for an arbitrary nx1 , it holds across
the distribution of sample sizes for which no strata cells are empty.
